FORTRESS BIOTECH, INC.

NEW YORK, NY How do I update this listing?

Fortress Biotech is based out of New York. Bio-pharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of inflammatory diseases and cancer.Whalewisdom has at least 10 13D filings, 1 13G filings, and 45 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2018-03-13. The notice included securities offered of Debt

Create Alert

Contact Info

fortress biotech, inc.
2 GANSEVOORT STREET
NEW YORK NY    10014

Business Phone: 781-652-4500
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
Avenue Therapeutics Inc (ATXI) HEALTH CARE 3,840,096 41,588,239.68 1 13D 2018-02-17
Mustang Bio Inc (MBIO) HEALTH CARE 12,120,354 32,482,548.72 2 13D 2017-08-03
Checkpoint Therapeutics Inc (CKPT) HEALTH CARE 11,435,515 17,267,627.65 3 13D 2018-01-01
NA (FECAX) 10,382,653 4 13D 2017-03-13

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2018-03-13 D BIOTECHNOLOGY Debt 30,000,000 6,517,000 23,483,000
2017-04-19 D BIOTECHNOLOGY Debt,Option, Warrant or Other Right to Acquire Another Security INDEFINITE 3,254,000 INDEFINITE
2011-07-05 D/A PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 28,765,040 25,784,568 2,980,472
2011-06-06 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 26,785,044 2,733,839 24,051,205
2011-05-09 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 82,200 0 82,200
2011-02-08 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 68,500 0 68,500
2011-01-19 D PHARMACEUTICALS Equity 14,118,534 14,118,534 0
2010-06-08 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 27,499,987 3,989,940 23,510,047
2010-05-07 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 7,700,002 7,000,000 700,002
2009-08-04 D PHARMACEUTICALS Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other 3,500,000 1,240,000 2,260,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
BERTRAND LIANG subscription required
    DIRECTOR
BOBBY W. SANDAGE subscription required
    EXECUTIVE OFFICER
DALE RITTER subscription required
    EXECUTIVE OFFICER
DAVID J. BARRETT subscription required
    DIRECTOR
DOV KLEIN subscription required
    DIRECTOR
ELIZABETH MOORE subscription required
    EXECUTIVE OFFICER
ERIC K. ROWINSKY subscription required
    DIRECTOR
GARY GEMIGNANI subscription required
    EXECUTIVE OFFICER
GEORGE AVGERINOS subscription required
    EXECUTIVE OFFICER
GLENN L. COOPER subscription required
    DIRECTOR
J. JAY LOBELL subscription required
    DIRECTOR
JIMMIE HARVEY subscription required
    DIRECTOR
JIMMIE HARVEY, JR. subscription required
    DIRECTOR
LINDA ROGERS subscription required
    EXECUTIVE OFFICER
LINDSAY A. ROSENWALD subscription required
    DIRECTOR
LUCY LU subscription required
    EXECUTIVE OFFICER
MALCOLM HOENLEIN subscription required
    DIRECTOR
MICHAEL W. ROGERS subscription required
    DIRECTOR
MICHAEL S. WEISS subscription required
    DIRECTOR
PEGGY WENTWORTH subscription required
    EXECUTIVE OFFICER
RAYMOND J. TESI subscription required
    EXECUTIVE OFFICER DIRECTOR
ROBYN HUNTER subscription required
    EXECUTIVE OFFICER
STEPHEN PILATZKE subscription required
    EXECUTIVE OFFICER
TIMOTHY M. HILLMAN subscription required
    EXECUTIVE OFFICER
TIMOTHY M. HOFER subscription required
    EXECUTIVE OFFICER

Elevate your investments